These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8851505)

  • 1. Effects of a selective adenosine A1 receptor antagonist on the development of cyclosporin nephrotoxicity.
    Balakrishnan VS; von Ruhland CJ; Griffiths DF; Coles GA; Williams JD
    Br J Pharmacol; 1996 Mar; 117(5):879-84. PubMed ID: 8851505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of nifedipine on cyclosporine nephrotoxicity in rats.
    Ferguson CJ; von Ruhland C; Parry-Jones DJ; Williams JD; Salaman JR
    Transpl Int; 1992; 5 Suppl 1():S490-3. PubMed ID: 14621856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of neutral endopeptidase potentiates the effects of atrial natriuretic peptide on acute cyclosporin-induced nephrotoxicity.
    Capasso G; Unwin R; Ciani F; Rizzo A; Russo F; Pica A; De Santo NG
    Nephron; 2000 Nov; 86(3):298-305. PubMed ID: 11096287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of silibinin on experimental cyclosporine nephrotoxicity.
    Zima T; Kameníková L; Janebová M; Buchar E; Crkovská J; Tesar V
    Ren Fail; 1998 May; 20(3):471-9. PubMed ID: 9606735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose cyclosporin nephrotoxicity in the rat.
    Ferguson CJ; von Ruhland C; Parry-Jones DJ; Griffiths DF; Salaman JR; Williams JD
    Nephrol Dial Transplant; 1993; 8(11):1259-63. PubMed ID: 8302466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of nifedipine on renal haemodynamics in an animal model of cyclosporin A nephrotoxicity.
    McNally PG; Baker F; Mistry N; Walls J; Feehally J
    Clin Sci (Lond); 1990 Sep; 79(3):259-66. PubMed ID: 2169375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional role of endogenous adenosine in human chronic renal disease.
    Balakrishnan VS; Coles GA; Williams JD
    Exp Nephrol; 1996; 4(1):26-36. PubMed ID: 8788597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissolving intravenous cyclosporin A in a fat emulsion carrier prevents acute renal side effects in the rat.
    Tibell A; Larsson M; Alvestrand A
    Transpl Int; 1993 Mar; 6(2):69-72. PubMed ID: 8447927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the prostacyclin analogue iloprost on cyclosporin-induced renal hypoperfusion in stable renal transplant recipients.
    Hansen JM; Christensen NJ; Fogh-Andersen N; Strandgaard S
    Nephrol Dial Transplant; 1996 Feb; 11(2):340-6. PubMed ID: 8671790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of STZ-induced diabetes and its treatment with vanadyl sulphate on cyclosporine A-induced nephrotoxicity in rats.
    Saad SY; Najjar TA
    Arch Toxicol; 2005 Sep; 79(9):493-9. PubMed ID: 15940472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effect of L-propionylcarnitine in chronic cyclosporine-a induced nephrotoxicity.
    Origlia N; Migliori M; Panichi V; Filippi C; Bertelli A; Carpi A; Giovannini L
    Biomed Pharmacother; 2006 Feb; 60(2):77-81. PubMed ID: 16472963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sustained renal function loss in psoriasis patients after withdrawal of low-dose cyclosporin therapy.
    Korstanje MJ; Bilo HJ; Stoof TJ
    Br J Dermatol; 1992 Nov; 127(5):501-4. PubMed ID: 1467290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of cyclosporin nephrotoxicity with a platelet-activating factor (PAF) antagonist.
    Bagnis C; Deray G; Dubois M; Pirotzky E; Jacquiaud C; Baghos W; Aupetit B; Braquet P; Jacobs C
    Nephrol Dial Transplant; 1996 Mar; 11(3):507-13. PubMed ID: 8671822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of nifedipine on cyclosporin A nephrotoxicity after unilateral nephrectomy in the spontaneously hypertensive rat.
    McNally PG; Baker F; Mistry N; Walls J; Feehally J
    Clin Sci (Lond); 1991 Aug; 81(2):271-9. PubMed ID: 1653673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antagonist capacities of nifedipine, captopril, phenoxybenzamine, prostacyclin and indomethacin on cyclosporin A induced impairment of rat renal function.
    Dieperink H; Leyssac PP; Starklint H; Jørgensen KA; Kemp E
    Eur J Clin Invest; 1986 Dec; 16(6):540-8. PubMed ID: 3104056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal function after 10 years' treatment with cyclosporin for psoriasis.
    Powles AV; Hardman CM; Porter WM; Cook T; Hulme B; Fry L
    Br J Dermatol; 1998 Mar; 138(3):443-9. PubMed ID: 9580797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A trial of the prostaglandin E1 analogue, enisoprost, to reverse chronic cyclosporine-associated renal dysfunction.
    Pollak R; Knight R; Mozes MF; Maddux M; Veremis S; Van Buren C; Lewis R; Scott E; Cole M; Hyndman V
    Am J Kidney Dis; 1992 Oct; 20(4):336-41. PubMed ID: 1415200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is there a beneficial effect of the calcium channel blocker diltiazem on cyclosporine A nephrotoxicity in rats?
    Kuhn UD; Lupp A; Kostka E; Kühl A; Balogh A; Stein G; Fleck C
    Exp Toxicol Pathol; 1998 Sep; 50(4-6):484-90. PubMed ID: 9784027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nephrotoxicity of cyclosporine A in rats with a diminished renal function.
    Provoost AP; Kaptein L; Van Aken M
    Clin Nephrol; 1986; 25 Suppl 1():S162-7. PubMed ID: 3519023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Normal renal function 8 to 13 years after cyclosporin A therapy in 285 diabetic patients.
    Assan R; Blanchet F; Feutren G; Timsit J; Larger E; Boitard C; Amiel C; Bach JF
    Diabetes Metab Res Rev; 2002; 18(6):464-72. PubMed ID: 12469360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.